Table 4 Comparison of clinical characteristics between patients with hematological malignancies and non-malignancies (N = 33)
Variables | Patients with hematological malignancies (%) (N = 12) | Patients with hematological non-malignancies (%) (N = 21) | P value |
|---|---|---|---|
Age, years | 52.5 (16–79) | 50 (20–77) | 0.586 |
Sex, female | 3 (25.0) | 16 (76.2) | 0.126 |
Non-hematological underlying conditions | |||
Chronic kidney diseases | 0 (0) | 2 (9.5) | 0.523 |
Splenectomy | 0 (0) | 2 (9.5) | 0.523 |
Rectal cancer | 0 (0) | 1 (4.8) | 1.000 |
Chemotherapy | 8 (66.7%) | 0 (0) | <0.0001 |
Glucocorticoids administration | 8 (66.7%) | 20 (95.2%) | 0.047 |
Sites of cryptococcal infection | |||
Brain | 6 (50.0) | 20 (95.2) | 0.001 |
Lung | 8 (66.7) | 8 (38.1) | 0.157 |
Blood | 1 (8.3) | 2 (9.5) | 1.000 |
Sinus | 1 (8.3) | 1 (4.8) | 1.000 |